SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-040128
Filing Date
2024-04-02
Accepted
2024-04-02 16:02:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A sndx-2024-04-02-defa_14a.htm DEFA14A 15454
2 GRAPHIC img74557388_0.jpg GRAPHIC 1205861
3 GRAPHIC img74557388_1.jpg GRAPHIC 275194
  Complete submission text file 0000950170-24-040128.txt   2056470
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37708 | Film No.: 24814078
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)